Health Signal Pro

Signals for reading - not a script, not a fill. Open the signal disclaimer.

Anticonvulsant / neuropathic-pain agent · HSP-06

Kidney-line gabapentin: why the 600 mg capsule is not a default

Creatinine clearance writes the 600 mg plan before this desk will talk about a cheap 90-count. Gabapentin leaves the body unchanged in the urine. With a working kidney the half-life is five to seven hours. When clearance falls under 30 mL/min that half-life can stretch toward two days. A 'standard' 600 mg three times daily in a quietly failing kidney is how older patients arrive oversedated and on the floor. The name Neurontin still tricks people. Chemists built a GABA look-alike. The drug does not bind GABA receptors in any useful way. It occupies the alpha-2-delta subunit of voltage-gated calcium channels and turns down excitatory release. FDA licences are narrow - adjunctive partial-onset seizures and postherpetic neuralgia - while everyday prescribing is wide. December 2019 added a breathing warning when gabapentinoids sit next to opioids or other depressants.

  • Ping: creatinine clearance before any 600 mg price
  • Target: alpha-2-delta, not GABA receptors
  • Exit: unchanged in urine; half-life 5-7 h if kidneys work
  • Stop: taper at least a week; never abrupt
Neurontin 600 mg capsules on a fog card next to an eGFR scribble

Creatinine clearance before any 600 mg price

The kidney is the ping. The 600 mg tablet is a tool, not a default. Opioids are the flag that can stop the combination.

Creatinine clearance writes the 600 mg plan, and I will keep repeating that because it is the error I see most. The US label's renal table is not optional colour. At clearance 60 mL/min or above, daily totals from 900 to 3600 mg in three doses are on the map, and 600 mg three times daily is a common maintenance step. Between 30 and 59 the day shrinks and the schedule often becomes twice daily. Below 30 you are in once-daily territory, and dialysis adds a supplemental swallow after the session.

Neurontin 600 mg tablets and 600 mg-capable capsule maths look tidy on a discharge list. They are tidy only if the kidney number is current. An eGFR copied from last winter is not a kidney line. Older people lose clearance faster than the chart looks, and a 'normal creatinine' can hide a low clearance in a small adult.

Price talk without that number is theatre. A cheap 90-count of 600 mg is a bargain only for the patient whose clearance can carry it. For everyone else it is a sedating overdose on a grocery receipt.

A 90-count of 600 mg after the creatinine line

Kidney-legal 600 mg nineties, from GoodRx and Bing listings in August 2026 for gabapentin 600 mg × 90. Coupon sites stay in this caption - they are not row links. Each href opens that company's own pharmacy page. A cheap 90-count does not rewrite the renal table.
Licensed deskCount we pricedCash lane we sawWhy it sits here
Walmart PharmacyGabapentin 600 mg × 90Big-box cash often high-teens to low-20sWalk-in Rx; confirm the schedule matches CrCl
Publix PharmacyGabapentin 600 mg × 90Grocery cash usually low-20sGrocery Rx desk; not a coupon-site href
Amazon PharmacyGabapentin 600 mg × 90Mail often low-20s on a 90-countDoorstep fill; still needs a current kidney number
Cost Plus DrugsGabapentin 600 mg × 90Transparent cash often the leanest of the four, mid-to-high teens before shippingMail-order cash desk; shipping is extra

Generic gabapentin is one of the cheaper nervous-system drugs in a US pharmacy, which is part of why it is written so freely. This desk priced a 90-count of 600 mg - a three-times-daily month if the kidney allows that schedule - at four licensed counters. Coupon sites stay in the caption. Row links open the chain's own pharmacy page.

Cost Plus Drugs often posts the leanest transparent cash of this set, mid-to-high teens before shipping on many common generics. Walmart big-box cash for this count usually sits high-teens to low-20s. Publix grocery cash and Amazon mail often land in the low-20s. Retail stickers without a card can look several times higher, which is why people think the drug is expensive when they have only seen the un-couponed chain number.

A 90-count is a lot of milligrams if someone is supposed to be on 300 mg three times daily. Do not let a 'bigger bottle is cheaper' habit overwrite the renal table. This desk does not ship capsules.

The GABA nickname that does not bind GABA

Chemists borrowed a neurotransmitter's nickname and built a molecule that could cross into the brain, which GABA itself does poorly. The design reached the brain and then refused to act at GABA receptors. It does not become GABA. It does not block GABA breakdown. Residents who reason from the syllables write the wrong counselling script.

Alpha-2-delta is the actual handle. That auxiliary subunit sits on voltage-gated calcium channels at nerve terminals. Occupying it reduces calcium influx when a terminal is over-firing, which cuts excitatory transmitter release. Quieter terminals are useful in a focal-seizure network and in a damaged sensory nerve that keeps shouting.

That is also why ordinary mechanical back pain and inflammatory arthritis are a mismatch. If the pain is not nerve-driven, you are buying dizziness for a problem the target does not see. The approval history that left us with this misleading name is in the journal note on how gabapentin was licensed, and how the name stuck.

Two FDA licences, a crowded off-label street

UseFDA statusDesk reading
Partial-onset seizures, adjunctLicensedAdd-on; not usually monotherapy first
Postherpetic neuralgiaLicensedNerve pain after shingles; titrate, do not expect erasure
Diabetic neuropathyOff-labelReasonable evidence; pregabalin holds the formal approval
Anxiety, RLS, mixed painOff-labelEvidence thins; do not treat as labelled

Adjunctive partial-onset seizures - add-on, from age three upward on the current US label - and postherpetic neuralgia in adults are the licensed pair. Gabapentin is rarely a first-choice single seizure drug. It earns a place because it has almost no hepatic CYP traffic and combines cleanly, until you reach the depressant stack.

Diabetic nerve pain is the off-label use with the least embarrassing evidence, even though the formal neuropathic-pain approval in that lane went to pregabalin. Restless legs, anxiety, and assorted pain syndromes pull a huge volume of scripts on thinner data. Off-label is allowed. Pretending it is labelled is not.

Aggressive marketing for unapproved uses became a legal case in the 2000s. That history is why some clinicians still flinch at the brand name and why this desk separates licence from habit. Trial-by-trial reading is in the journal note on what the gabapentin evidence actually carries.

Saturable gut, almost no liver, unchanged urine

Absorption
Oral via a saturable transporter. Fraction absorbed falls as the daily total climbs, so split the day rather than stacking 600 mg tablets at one sitting.
Distribution
Enters the central nervous system; low protein binding. Not a displacement-interaction drug.
Metabolism
Essentially none. No meaningful hepatic CYP traffic, which is why the dangerous stacks are sedative, not metabolic.
Excretion
Renal, as unchanged drug. Half-life 5-7 hours if clearance is decent; can stretch toward 52 hours when CrCl is under 30. Supplemental dose after haemodialysis.

A limited gut transporter takes gabapentin in. Bioavailability falls as the swallow grows - about 60 percent at 900 mg a day, about 47 percent at 1200, about 34 percent at 2400, about 27 percent at 3600. One giant 600 mg-plus dump does not double the effect. Three smaller swallows capture more drug and keep the level less peaky. That is why three-times-daily exists.

Hepatic metabolism is essentially absent. CYP interaction lists that haunt other anticonvulsants mostly do not apply. The interactions that hurt people are pharmacodynamic: stacked sedation and stacked respiratory depression. Aluminium or magnesium antacids cut absorption; separate them by about two hours.

Protein binding is low. Dialysis removes the drug, which is why a post-session supplemental dose is on the label. The kidney number is not a side quest. It is the dose.

Climb slowly, leave over at least a week

SituationTypical approachHold
Postherpetic neuralgiaTitrate toward ~1800 mg/day in 3 doses if CrCl allowsSlow climb; 600 mg TID is not day one
Partial seizures, adjunct900-1800 mg/day typical; up to 3600 if tolerated and CrCl ≥60Never stop abrupt
CrCl 30-59Lower daily total, often BIDDo not keep 600 mg TID by habit
HaemodialysisMaintenance by residual clearance plus a post-session supplementLabelled supplemental range, not a guess

Postherpetic neuralgia often opens at 300 mg on day one, 300 mg twice on day two, 300 mg three times on day three, then climbs toward 1800 mg a day in divided swallows if the kidney allows. Seizure add-on totals can run higher, up to 3600 mg a day in people with clearance at or above 60. Jumping straight to 600 mg three times daily is how dizziness and somnolence arrive on night two.

Stopping is the other half of the schedule. Abrupt withdrawal can precipitate a seizure, including in someone who was taking the drug 'only for pain'. Even without a seizure, anxiety, sweating, and insomnia show up. Taper over at least a week, longer after high doses or long use. This is not a tablet you abandon in a hotel.

The 600 mg tablet is a maintenance brick, not a starter. Capsules at 100, 300, and 400 mg exist so the climb and the renal cuts can be honest. The practical titration and hold list is in the journal note on dosing gabapentin without skipping the kidney line.

December 2019: breathing when opioids sit next door

StackConcernPractical step
OpioidsRespiratory depression; potentiation and diversionAvoid or use lowest doses with a watcher for slow breathing
Benzodiazepines, alcohol, other sedativesAdditive sedation and hypoventilationCaution, especially in older or lung-limited patients
Aluminium / magnesium antacidsLower gabapentin absorptionSeparate by about 2 hours
Falling CrClAccumulation, oversedation, fallsRecut dose and interval; do not keep 600 mg TID

FDA posted a gabapentinoid warning in December 2019: serious, life-threatening respiratory depression when gabapentin or pregabalin sits with opioids or other central depressants, and in people with already-fragile breathing or advanced age. Reports included deaths. The 'soft' reputation did not survive that file.

Gabapentin can also potentiate an opioid high, which is why diversion exists and why several US states moved it onto monitored lists. I do not treat a long, unreviewed refill chain as harmless. I also do not yank a useful nerve-pain drug from a patient who is not stacked with sedatives. The combination is the flag.

Alcohol is in the same depressant family. A small drink is a judgement call. Regular heavy drinking on 600 mg three times daily is a coordination and breathing problem, worse if a benzodiazepine is already in the evening cup.

Dizziness, a fall, a mood watch

Somnolence and unsteadiness are the early tax. They track the speed of the climb more than the brand name on the bottle. In a frail patient they are a fracture risk, not a 'she'll get used to it' shrug. Peripheral oedema and a little weight gain show up with longer use in some people. Blurred or double vision happens.

Anticonvulsants as a class carry a warning about new or worsening depression, anxiety, or suicidal thinking. Most patients notice nothing. Families still need the sentence: a real mood shift after a start or a climb is a same-week call, not a wait-until-review item.

Misuse potential is higher than the mellow reputation. That does not make every 600 mg prescription a street drug. It does mean I ask about prior substance trouble and I do not shrug at early refill requests. MedlinePlus keeps a plain overview if a household wants a second, non-clinic page.

1993 seizures, 2002 shingles pain, then the marketing case

1970s-1980s

GABA-mimic design; the finished drug does not act at GABA receptors.

1993

FDA approves Neurontin as adjunctive therapy for partial-onset seizures.

2002

Approval for postherpetic neuralgia in adults.

2004 era

Major settlement around off-label promotion; prescribing already far past the label.

2019

FDA warns of serious breathing problems with opioids and other CNS depressants.

FDA first posted gabapentin in 1993 as an add-on for partial seizures. The 2002 postherpetic-neuralgia approval opened the nerve-pain door where most of the eventual volume would live. Neither licence predicted how wide the off-label street would become.

The off-label promotion case in the mid-2000s is part of the drug's public memory. I mention it so a reader understands why a cheap, familiar capsule can still carry a wary footnote on this desk. Familiar is not the same as labelled. Cheap is not the same as kidney-safe.

Horizant (gabapentin enacarbil) and Gralise (extended-release gabapentin) are related but not swap-in brands for a Neurontin 600 mg tablet. Different licences, different schedules. Do not let a pharmacy computer treat every 'gabapentin' string as one product.

What Nathan posts after the kidney line

Gabapentin is a useful, usually well-tolerated drug for the two licensed jobs and for some nerve-pain rooms with decent evidence. The 600 mg tablet is a maintenance brick for people whose clearance can carry it. It is not a first swallow and not a default in anyone over seventy until I have a current CrCl.

Taper off. Do not stack it casually with opioids. Recut the schedule when the kidney slips. Those three sentences prevent most of the harm I see. The rest - saturable absorption, a misleading name, a cheap 90-count - is detail around that core.

If dizziness is brutal, if breathing looks slow, or if mood shifts, we stop climbing and we look at the stack. We do not add a second sedative to 'help sleep' on top of a 600 mg three-times-daily habit. And we do not change a swallow from a teaching page. Take the kidney number and the full list to the clinician who actually follows you, including if that person is comparing a steroid course such as prednisone (Deltasone) in the same month.

Portrait of Dr. Nathan Whitfield on a Health Signal Pro fog card

Forum

The clinic thread

Answered by Dr. Nathan Whitfield, MD · Internal medicine & clinical pharmacology

I will not talk Neurontin 600 mg price until I have a creatinine clearance. These are the questions that follow that sentence in clinic.

Why won't you quote a 90-count price until you see my kidney numbers?

Because gabapentin leaves unchanged in the urine, and a 600 mg three-times-daily month is a very different exposure at CrCl 70 than at CrCl 35. I have seen older patients fill a cheap 90-count on a stale eGFR and arrive oversedated. The cash band at Walmart or Cost Plus is real. It is also irrelevant if the schedule is wrong. Bring a current creatinine. Then we talk about a 90-count.

My script says 600 mg. Is that a starting dose?

Usually not. 600 mg is a maintenance brick after a climb, and only if your clearance can carry a high daily total. Many people start at 300 mg and step up over several days to limit dizziness. Jumping to 600 mg three times daily on day one is a common reason the first week feels awful. If 600 mg is what was written, I still want to know your CrCl and whether anyone titrated you there on purpose.

The name sounds like a calming brain chemical. Is that how it works?

The syllables are a leftover. Chemists wanted a GABA look-alike that could enter the brain. Once there, gabapentin does not bind GABA receptors in any useful way. It sits on the alpha-2-delta subunit of calcium channels and quiets over-firing terminals. That is how it helps some seizures and some nerve pain. If you reason from the name, you will expect a benzodiazepine and then be surprised by the kidney maths.

What is Neurontin actually licensed to treat?

Two things on the US label: add-on treatment for partial-onset seizures, and postherpetic neuralgia - the burning nerve pain that can linger after shingles. Diabetic nerve pain, anxiety, restless legs, and mixed back pain are off-label. Off-label can still be reasonable, especially for diabetic neuropathy, but you deserve to hear when a use sits outside the licence. I will say that out loud rather than let a 600 mg tablet imply an approval.

I want to stop it this weekend. Can I just not refill?

Please do not. Sudden withdrawal can trigger a seizure, including in people who were taking it for pain rather than epilepsy. Anxiety, sweating, and broken sleep are common even without a seizure. We taper over at least a week, longer if you have been on a high daily total. If you want off, tell me and we write a step-down. A skipped 90-count is not a taper.

I take oxycodone for my back. Is gabapentin still all right?

It can be a serious stack. In December 2019 the FDA warned that gabapentinoids plus opioids, or plus other sedatives, can slow or stop breathing, especially in older people and anyone with lung disease. I do not always forbid both, but I use the lowest doses, I watch for extreme sleepiness or slow breathing, and I do not let you add extra tablets of either on a bad night. If the pain plan can lose one of the two, that is safer.

Why three times a day instead of one 600 mg at night?

Your gut absorbs gabapentin through a transporter that saturates. A single large swallow wastes a bigger fraction. Split doses capture more drug and keep the level steadier, which matters for both seizures and nerve pain. Night-only 600 mg is a common home-made schedule that looks simpler and then underperforms. If sedation is the problem, we change the total or the kidney maths - we do not invent a once-daily Neurontin that the immediate-release label does not support.

I am dizzy and I nearly fell. Is the drug wrong for me?

Dizziness is the most common early tax, especially after a fast climb or when the kidney is holding onto the drug. It is not proof the choice was foolish, and it is not something to 'push through' if you are falling. Tell me how bad it is. We slow the titration, cut the milligram, or recut for clearance. In someone your age a fall is a bigger harm than a slightly slower pain response.

How long before shingles-nerve pain eases?

Not overnight. We titrate over days to weeks, and the honest goal is less pain, not a clean erase. People abandon a drug that was starting to help because they expected a switch. Give a fair climb to an adequate, kidney-legal total before we call it a failure. MedlinePlus is a decent plain-language companion if you want something to read between visits.

Can I take my magnesium antacid with the capsule?

Not at the same moment. Aluminium or magnesium antacids cut how much gabapentin you absorb, so a 600 mg tablet taken with the antacid can behave like a smaller dose. Separate them by about two hours. Beyond antacids, metabolic interactions are scarce because the liver barely touches this drug. The dangerous company is still opioids and other sedatives, not the usual blood-pressure list.

People online say it is addictive. Should I be worried?

It has more misuse and dependence potential than its calm reputation. Some people take it to intensify opioids, and several states monitor it for that reason. Most patients on a labelled or well-chosen off-label plan do not run into that. I still ask about prior substance trouble, I do not rubber-stamp early refills, and I taper rather than stop. If that history is yours, say so. It changes how tightly I follow the bottle, not whether nerve pain deserves treatment.

Is a glass of wine off limits on 600 mg?

I would be cautious. Alcohol and gabapentin both depress the central nervous system, so dizziness, sleepiness, and coordination stack. An occasional small glass is a judgement I can live with for many people. Regular or heavy drinking on a 600 mg three-times-daily schedule is a bad mix, and a worse one if an opioid or a benzodiazepine is already in the evening. Tell me what you actually drink so the advice fits you, not a pamphlet.

Could this change my mood?

It can, in a small number of people, the way other anticonvulsants can. New or worsening depression, anxiety, or thoughts of self-harm are a same-week call. Most patients notice nothing of the sort. I still give families that sentence at the start so a real shift is not written off as 'just the pain'. It is a watch, not a reason to fear a useful drug in advance.

I am on haemodialysis. Do I still take 600 mg three times a day?

Almost certainly not. Dialysis removes gabapentin, and the label uses a lower maintenance total based on residual clearance plus a supplemental dose after each session. A leftover 600 mg three-times-daily habit from before dialysis is a common, dangerous leftover. Bring the dialysis days to the visit so we can write the post-session swallow on purpose rather than guess from an old 90-count.

General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.

Last Updated

Gabapentin 4.9 / 5 from 2555 patient reviews

Health Signal Pro

Nine medicines, read the way a pharmacist reads a label.

Referenced drug notes, a research journal, and three specialists who answer the questions readers actually send.

Open the drug index